Training Manual for Preventive Malaria - Ministry of Health
Training Manual for Preventive Malaria - Ministry of Health
Training Manual for Preventive Malaria - Ministry of Health
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
• IPT with SP when delivered as part <strong>of</strong> antenatal care significantly reduces the<br />
prevalence <strong>of</strong> maternal anaemia and placental parasitemia and the incidence <strong>of</strong> low birth<br />
weight.<br />
Studies in Kenya and Malawi have shown that IPT with SP has a beneficial impact on<br />
maternal and infant health<br />
• Although there are concerns that sulfa drugs may be associated with kernicterus when<br />
given to premature neonates, this problem has not been noted in studies <strong>of</strong> IPT where<br />
Sulfadoxine Pyrimethamine (SP) has been administered to the mother.<br />
• Studies examining the risk to the foetus from uterine exposure to SP<br />
have generally not found any increased risk in spontaneous abortions or congenital<br />
defects. One retrospective study <strong>of</strong> antifolate drugs given be<strong>for</strong>e and during pregnancy<br />
did find that there was an increased risk <strong>of</strong> birth defects when such drugs were taken<br />
during the first trimester, but not during the second or third trimester.<br />
DOSAGE<br />
Sulphadoxine – Pyrimethamine (SP) or Fansidar should be given as single adult dose (3 tablets)<br />
at regularly scheduled antenatal care visits during the second and third trimesters.<br />
Up to a maximum <strong>of</strong> 3 doses is recommended by the <strong>Ministry</strong> <strong>of</strong> <strong>Health</strong>.<br />
1 st . Dose: Given after quickening or after (16 weeks)<br />
2 nd . Dose: At least one month after the first dose.<br />
3 rd . Dose: At least one month after the second dose.<br />
ADMINISTRATION<br />
Sulphadoxine-pyrimethamine should be given at the ANC clinic or at where there is<br />
supervision <strong>of</strong> a midwife/health worker through a Directly Observed Treatment (DOT)<br />
Method.<br />
Step 1<br />
° When a pregnant woman comes to the clinic be<strong>for</strong>e quickening, in<strong>for</strong>m her to come back<br />
<strong>for</strong> her next regularly scheduled ANC visit.<br />
° Screen the pregnant woman <strong>for</strong> history <strong>of</strong> allergy to Sulpha drugs and record in maternal<br />
health record book.<br />
° If quickening has occurred, ask the pregnant woman whether she has received treatment<br />
with SP in the past one month. If she has, ask her to return one month after the last SP dose.<br />
Proceed to step 2.<br />
30